RE:RE:RE:RE:News ReleaseSo they did submit the IND for NAShin November, maybe more than few weeks but not bad imo.
Question is how fast they complete the meeting with agencies?
They intend to start that trial by end of third quarter and it is going be phase 3 not phase 2b.
Sales are impressive too in the midst of the pandemic.
Cancer is on schedule.
I believe this is overall a good PR.
1- NASH wil bd straight phase 3.
2- Cancer protocol is on schedule.
3-Sales are growing.
4- They did submit both INDs in sort of timely manner.